Literature DB >> 23917908

Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009.

Marya D Zilberberg1, Andrew F Shorr.   

Abstract

OBJECTIVE: Urinary tract infections (UTIs) are common among hospitalized patients. Selection of an appropriate antibiotic for this infection requires knowledge of both its general microbiology and the epidemiology of drug-resistant organisms. We sought to determine secular trends in UTI hospitalizations that involve gram-negative (GN) multidrug-resistant Pseudomonas aeruginosa (MDR-PA), extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (EC) and Klebsiella pneumoniae (KP), and carbapenem-resistant Enterobacteriaceae (CRE).
DESIGN: Survey. PATIENTS: Patients with UTI in US hospitals between 2000 and 2009.
METHODS: We first derived the total number of UTI hospitalizations in the United States from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample database years 2000-2009. Based on a literature review, we then determined what proportion of all UTIs arise due to each of the organisms of interest, irrespective of resistance pattern. Finally, we assessed the prevalence of resistance within each pathogen based on the Eurofins Surveillance Network database 2000-2009. Susceptibility patterns served as phenotypic surrogates for resistance.
RESULTS: Between 2000 and 2009, the frequency of UTI hospitalizations increased by approximately 50%, from 53 to 77 cases per 1,000 hospitalizations. Infections due to all GN bacteria followed a similar trajectory, whereas those caused by resistant GN pathogens increased by approximately 50% (MDR-PA) to approximately 300% (ESBL). CRE emerged and reached 0.5 cases per 1,000 hospitalizations in this 10-year period.
CONCLUSIONS: The epidemiology and microbiology of GN UTI hospitalizations has shifted over the past decade. The proportion of all hospitalizations involving this infection has climbed. Resistant GN bacteria are becoming more prevalent and are implicated in an increasing proportion of UTIs among hospitalized patients.

Entities:  

Mesh:

Year:  2013        PMID: 23917908     DOI: 10.1086/671740

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  45 in total

1.  Perceptions and behaviours of infectious diseases physicians when managing urinary tract infections due to MDR organisms.

Authors:  Sergio E Trevino; Hilary M Babcock; Jeffrey P Henderson; Michael A Lane; Susan E Beekmann; Philip M Polgreen; Jonas Marschall
Journal:  J Antimicrob Chemother       Date:  2015-09-07       Impact factor: 5.790

2.  Effects of Clostridium difficile infection in patients with alcoholic hepatitis.

Authors:  Vinay Sundaram; Folasade P May; Vignan Manne; Sammy Saab
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-27       Impact factor: 11.382

3.  The importance of the Pseudomonas aeruginosa type III secretion system in epithelium traversal depends upon conditions of host susceptibility.

Authors:  Aaron B Sullivan; K P Connie Tam; Matteo M E Metruccio; David J Evans; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

4.  Warmer weather as a risk factor for hospitalisations due to urinary tract infections.

Authors:  J E Simmering; J E Cavanaugh; L A Polgreen; P M Polgreen
Journal:  Epidemiol Infect       Date:  2018-01-08       Impact factor: 2.451

5.  Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis.

Authors:  M-A Vibet; J Roux; E Montassier; S Corvec; M-E Juvin; C Ngohou; D Lepelletier; E Batard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-24       Impact factor: 3.267

6.  Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria.

Authors:  Zubair A Qureshi; Alveena Syed; Lloyd G Clarke; Yohei Doi; Ryan K Shields
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

7.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.

Authors:  Liam Toner; Nathan Papa; Sani H Aliyu; Harveer Dev; Nathan Lawrentschuk; Samih Al-Hayek
Journal:  World J Urol       Date:  2015-10-28       Impact factor: 4.226

8.  Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure.

Authors:  Deanna J Buehrle; Ryan K Shields; Lloyd G Clarke; Brian A Potoski; Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

9.  Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in U.S. Hospitals, 2013 to 2018.

Authors:  Marya D Zilberberg; Brian H Nathanson; Kate Sulham; Andrew F Shorr
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

10.  In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012.

Authors:  A Walkty; H Adam; M Baxter; A Denisuik; P Lagacé-Wiens; J A Karlowsky; D J Hoban; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.